Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Russian Journal for Personalized MedicineOpen Access

Pharmacogenetic testing in psychiatric practice

View Full Paper
Ask AI
Bookmark
Share

Authors

AKA. V. KidyaevaРНР. Ф. Насырова

Discussion

Loading...

Member takes

Overview

Review analyzes pharmacogenetic testing's role in optimizing drug metabolism in patients, suggesting reduced adverse effects.

Key Points

  • Pharmacogenetic testing can reduce the risk of adverse drug reactions, improving treatment outcomes for patients.
  • Identification of the cytochrome p450 enzymes' activity is crucial for effective use of psychotropic medications.
  • The review highlights the need for personalized medicine approaches in psychiatric care to enhance patient compliance.
  • Emerging pharmacogenetic testing strategies show promise in tailoring psychopharmacotherapy for individual patients.

Cite This Study

Kidyaeva et al. (2025) studied this question.

synapsesocial.com/papers/68c23cf6b210217d6478bbdfhttps://doi.org/10.18705/2782-3806-2025-5-3-261-271
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Patient and clinician perspectives on pharmacogenetic testing for antipsychotics2025
  2. 2Towards Personalized Psychiatry: Foreign Experience in Psychopharmacogenetics2025
  3. 3Pharmacogenetic Testing of Children and Adolescents with Mental Health Conditions: Real-World Experiences2025
  4. 4Evidence level for pharmacogenetic testing in antidepressant treatment: a systematic review2025 · 3 citations
  5. 5Advancing drug safety in psychiatry: insights from pharmacogenomics of hypersensitivity reactions2025